Hilltop National Bank Purchases Shares of 417 Axon Enterprise, Inc $AXON

Hilltop National Bank purchased a new stake in shares of Axon Enterprise, Inc (NASDAQ:AXON) in the second quarter, HoldingsChannel reports. The firm purchased 417 shares of the biotechnology company’s stock, valued at approximately $345,000.

A number of other institutional investors have also made changes to their positions in AXON. Jennison Associates LLC increased its position in shares of Axon Enterprise by 23,203.7% during the first quarter. Jennison Associates LLC now owns 614,053 shares of the biotechnology company’s stock valued at $322,961,000 after acquiring an additional 611,418 shares during the last quarter. Nuveen LLC acquired a new stake in shares of Axon Enterprise during the first quarter valued at about $264,796,000. Westfield Capital Management Co. LP increased its position in shares of Axon Enterprise by 29.8% during the first quarter. Westfield Capital Management Co. LP now owns 927,801 shares of the biotechnology company’s stock valued at $487,977,000 after acquiring an additional 212,931 shares during the last quarter. Vanguard Group Inc. increased its position in shares of Axon Enterprise by 2.2% during the first quarter. Vanguard Group Inc. now owns 8,632,008 shares of the biotechnology company’s stock valued at $4,540,005,000 after acquiring an additional 185,571 shares during the last quarter. Finally, Axiom Investors LLC DE acquired a new stake in shares of Axon Enterprise during the first quarter valued at about $93,088,000. 79.08% of the stock is currently owned by institutional investors and hedge funds.

Analysts Set New Price Targets

A number of equities research analysts have weighed in on the stock. UBS Group reiterated a “neutral” rating and set a $840.00 price target (up from $820.00) on shares of Axon Enterprise in a research report on Tuesday, August 5th. Craig Hallum upgraded shares of Axon Enterprise from a “hold” rating to a “buy” rating and set a $900.00 price objective for the company in a report on Tuesday, August 5th. JPMorgan Chase & Co. lifted their price objective on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an “overweight” rating in a report on Thursday, July 17th. Zacks Research cut shares of Axon Enterprise from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 2nd. Finally, Raymond James Financial restated an “outperform” rating and issued a $855.00 price objective (up previously from $645.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Fourteen analysts have rated the stock with a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $841.64.

Axon Enterprise Trading Down 0.7%

NASDAQ AXON opened at $715.51 on Friday. The company has a quick ratio of 2.71, a current ratio of 2.95 and a debt-to-equity ratio of 0.63. Axon Enterprise, Inc has a 52 week low of $413.68 and a 52 week high of $885.91. The stock has a market capitalization of $56.17 billion, a PE ratio of 176.67, a price-to-earnings-growth ratio of 27.98 and a beta of 1.41. The firm has a 50 day moving average of $757.79 and a two-hundred day moving average of $707.36.

Axon Enterprise (NASDAQ:AXON) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 EPS for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company had revenue of $668.54 million during the quarter, compared to analysts’ expectations of $641.77 million. During the same quarter in the previous year, the business posted $1.20 EPS. The firm’s revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, research analysts expect that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

Insider Buying and Selling at Axon Enterprise

In other news, CEO Patrick W. Smith sold 10,000 shares of the business’s stock in a transaction that occurred on Monday, September 8th. The shares were sold at an average price of $743.64, for a total transaction of $7,436,400.00. Following the completion of the sale, the chief executive officer owned 3,043,982 shares in the company, valued at approximately $2,263,626,774.48. The trade was a 0.33% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, President Joshua Isner sold 15,919 shares of the business’s stock in a transaction that occurred on Friday, August 15th. The stock was sold at an average price of $746.26, for a total transaction of $11,879,712.94. Following the sale, the president owned 238,379 shares of the company’s stock, valued at $177,892,712.54. This represents a 6.26% decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 49,932 shares of company stock worth $37,978,216. 4.40% of the stock is owned by insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.